120 related articles for article (PubMed ID: 35249728)
1. Factors associated with inability to return to intended oncologic treatment in pancreatic cancer.
Mickel TA; Kutlu OC; Silberfein EJ; Hsu C; Chai CY; Fisher WE; Van Buren G; Camp ER
Am J Surg; 2022 Jul; 224(1 Pt B):635-640. PubMed ID: 35249728
[TBL] [Abstract][Full Text] [Related]
2. Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study.
Naffouje SA; Kamarajah SK; Denbo JW; Salti GI; Dahdaleh FS
Ann Surg Oncol; 2022 Nov; 29(12):7793-7803. PubMed ID: 35960450
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
[TBL] [Abstract][Full Text] [Related]
4. Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base.
Sharpe SM; Talamonti MS; Wang CE; Prinz RA; Roggin KK; Bentrem DJ; Winchester DJ; Marsh RD; Stocker SJ; Baker MS
J Am Coll Surg; 2015 Jul; 221(1):175-84. PubMed ID: 26095569
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
[TBL] [Abstract][Full Text] [Related]
6. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.
Aloia TA; Zimmitti G; Conrad C; Gottumukalla V; Kopetz S; Vauthey JN
J Surg Oncol; 2014 Aug; 110(2):107-14. PubMed ID: 24846705
[TBL] [Abstract][Full Text] [Related]
7. Assessment of textbook oncologic outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.
Sweigert PJ; Eguia E; Baker MS; Paredes AZ; Tsilimigras DI; Dillhoff M; Ejaz A; Cloyd J; Tsung A; Pawlik TM
J Surg Oncol; 2020 May; 121(6):936-944. PubMed ID: 32124437
[TBL] [Abstract][Full Text] [Related]
8. Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma.
Nassour I; Winters SB; Hoehn R; Tohme S; Adam MA; Bartlett DL; Lee KK; Paniccia A; Zureikat AH
J Surg Oncol; 2020 Aug; 122(2):234-242. PubMed ID: 32350882
[TBL] [Abstract][Full Text] [Related]
9. Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer.
Min EK; Chong JU; Hwang HK; Pae SJ; Kang CM; Lee WJ
World J Gastroenterol; 2017 Jan; 23(4):676-686. PubMed ID: 28216975
[TBL] [Abstract][Full Text] [Related]
10. Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients.
Ramos MFKP; de Castria TB; Pereira MA; Dias AR; Antonacio FF; Zilberstein B; Hoff PMG; Ribeiro U; Cecconello I
J Gastrointest Surg; 2020 Jan; 24(1):19-27. PubMed ID: 31745892
[TBL] [Abstract][Full Text] [Related]
11. Thirty-day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
Mitsakos AT; Dennis SO; Parikh AA; Snyder RA
J Surg Oncol; 2021 Mar; 123(4):970-977. PubMed ID: 33497474
[TBL] [Abstract][Full Text] [Related]
12. Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.
Satoi S; Murakami Y; Motoi F; Sho M; Matsumoto I; Uemura K; Kawai M; Kurata M; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Kinoshita S; Akahori T; Shinzeki M; Fukumoto T; Hashimoto Y; Hirono S; Yamaue H; Honda G; Kwon M
Pancreas; 2016 Aug; 45(7):1003-9. PubMed ID: 26692442
[TBL] [Abstract][Full Text] [Related]
13. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage.
Vega EA; Kutlu OC; Salehi O; Alarcon SV; Abudalou M; Kozyreva O; Krishnan S; Lee D; Freeman R; Conrad C
Surg Oncol; 2022 Mar; 40():101694. PubMed ID: 34973593
[TBL] [Abstract][Full Text] [Related]
14. Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients.
Lu L; Zhang X; Tang G; Shang Y; Liu P; Wei Y; Gong P; Ma L
Int J Surg; 2018 May; 53():262-268. PubMed ID: 29604352
[TBL] [Abstract][Full Text] [Related]
15. Does a Laparoscopic Approach to Distal Pancreatectomy for Cancer Contribute to Optimal Adjuvant Chemotherapy Utilization?
Salehi O; Vega EA; Kutlu OC; Krishnan S; Sleeman D; De La Cruz Munoz N; Alarcon SV; Kazakova V; Kozyreva O; Conrad C
Ann Surg Oncol; 2021 Dec; 28(13):8273-8280. PubMed ID: 34125349
[TBL] [Abstract][Full Text] [Related]
16. Surgical Results of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: a Multi-institutional Retrospective Study of 174 patients.
Yamashita Y; Yoshizumi T; Fukuzawa K; Nishizaki T; Tsujita E; Kajiyama K; Soejima Y; Yamagata M; Yamamoto K; Adachi E; Sugimachi K; Ikeda Y; Uchiyama H; Maeda T; Itoh S; Harimoto N; Ikegami T; Maehara Y
Anticancer Res; 2016 May; 36(5):2407-12. PubMed ID: 27127150
[TBL] [Abstract][Full Text] [Related]
17. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
Lewis R; Drebin JA; Callery MP; Fraker D; Kent TS; Gates J; Vollmer CM
HPB (Oxford); 2013 Jan; 15(1):49-60. PubMed ID: 23216779
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution.
Stauffer JA; Coppola A; Villacreses D; Mody K; Johnson E; Li Z; Asbun HJ
Surg Endosc; 2017 May; 31(5):2233-2241. PubMed ID: 27604369
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
Fukumoto T; Watanabe T; Hirai I; Kimura W
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
